請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/102131完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 林俊彬 | zh_TW |
| dc.contributor.advisor | Chun-Pin Lin | en |
| dc.contributor.author | 馮大瑋 | zh_TW |
| dc.contributor.author | Tai-Wei Feng | en |
| dc.date.accessioned | 2026-03-13T16:40:53Z | - |
| dc.date.available | 2026-03-14 | - |
| dc.date.copyright | 2026-03-13 | - |
| dc.date.issued | 2026 | - |
| dc.date.submitted | 2026-01-21 | - |
| dc.identifier.citation | 1. Lin PY, Cheng YW, Chu CY, Chien KL, Lin CP, Tu YK. In-office treatment for dentin hypersensitivity: A systematic review and network meta-analysis. Journal of clinical periodontology 2013;40(1):53-64.
2. Matsuzaki K, Shimada Y, Shinno Y, Ono S, Yamaji K, Ohara N, et al. Assessment of demineralization inhibition effects of dentin desensitizers using swept-source optical coherence tomography. Materials (Basel) 2021;14(8). 3. Garcia R, Giannini M, Takagaki T, Sato T, Matsui N, Nikaido T, et al. Effect of dentin desensitizers on resin cement bond strengths. RSBO 2016;12:14. 4. Ishihata H, Kanehira M, Finger WJ, Takahashi H, Tomita M, Sasaki K. Effect of two desensitizing agents on dentin permeability in vitro. Journal of applied oral science : revista FOB 2017;25(1):34-41. 5. Mehta D, Gowda V, Santosh A, Finger W, Sasaki K. Randomized controlled clinical trial on the efficacy of dentin desensitizing agents. Acta Odontol. Scand. 2014;72:1-6. 6. Miyajima H, Ishimoto T, Ma S, Chen J, Nakano T, Imazato S. In vitro assessment of a calcium-fluoroaluminosilicate glass-based desensitizer for the prevention of root surface demineralization. Dent Mater J 2016;35(3):399-407. 7. Nomura Y, KoichiIwata, NakaoYoshikawa, KenjiYamamoto, Ken. Effect of various materials on dentin permeability for the treatment of dentin hypersensitivity. J. Conserv. Dent. 2013;56(6):516-525. 8. Kuo TC, Lee BS, Kang SH, Lin FH, Lin CP. Cytotoxicity of dp-bioglass paste used for treatment of dentin hypersensitivity. Journal of endodontics 2007;33(4):451-454. 9. Lee BS, Kang SH, Wang YL, Lin FH, Lin CP. In vitro study of dentinal tubule occlusion with sol-gel dp-bioglass for treatment of dentin hypersensitivity. Dental materials journal 2007;26(1):52-61. 10. Lee BS, Tsai HY, Tsai YL, Lan WH, Lin CP. In vitro study of dp-bioglass paste for treatment of dentin hypersensitivity. Dental materials journal 2005;24(4):562-569. 11. Chang HH, Yeh CL, Wang YL, Liu GW, Lin HP, Lin CP. Crystal growth in dentinal tubules with bio-calcium carbonate-silica sourced from equisetum grass. J Formos Med Assoc 2020. 12. Wang YL, Chiang YC, Chang HH, Lin HP, Lin CP. Novel calcium encapsulated mesocellular siliceous foams for crystal growth in dentinal tubules. Journal of dentistry 2019;83:61-66. 13. Chiang YC, Wang YL, Lin PY, Chen YY, Chien CY, Lin HP, et al. A mesoporous biomaterial for biomimetic crystallization in dentinal tubules without impairing the bonding of a self-etch resin to dentin. J. Formos. Med. Assoc. 2016;115(6):455-462. 14. Chiang YC, Lin HP, Chang HH, Cheng YW, Tang HY, Yen WC, et al. A mesoporous silica biomaterial for dental biomimetic crystallization. ACS Nano 2014;8(12):12502-12513. 15. Chiang YC, Chen HJ, Liu HC, Kang SH, Lee BS, Lin FH, et al. A novel mesoporous biomaterial for treating dentin hypersensitivity. J Dent Res 2010;89(3):236-240. 16. Goldberg M, Kulkarni AB, Young M, Boskey A. Dentin: Structure, composition and mineralization. Front Biosci (Elite Ed) 2011;3(2):711-735. 17. Lenzi TL, Guglielmi Cde A, Arana-Chavez VE, Raggio DP. Tubule density and diameter in coronal dentin from primary and permanent human teeth. Microsc Microanal 2013;19(6):1445-1449. 18. West NX, Lussi A, Seong J, Hellwig E. Dentin hypersensitivity: Pain mechanisms and aetiology of exposed cervical dentin. Clin Oral Investig 2013;17 Suppl 1:S9-19. 19. Brannstrom M. Dentin sensitivity and aspiration of odontoblasts. J Am Dent Assoc 1963;66:366-370. 20. Zeola LF, Soares PV, Cunha-Cruz J. Prevalence of dentin hypersensitivity: Systematic review and meta-analysis. J Dent 2019;81:1-6. 21. Demirci M, Karabay F, Berkman M, Özcan İ, Tuncer S, Tekçe N, et al. The prevalence, clinical features, and related factors of dentin hypersensitivity in the turkish population. Clin Oral Investig 2022;26(3):2719-2732. 22. Irvine JH. Root surface sensitivity: A review of aetiology and management. J N Z Soc Periodontol 1988(66):15-18. 23. Orchardson R, Cadden SW. An update on the physiology of the dentine-pulp complex. Dent Update 2001;28(4):200-206, 208-209. 24. Hill TJ. Pathology of the dental pulp. JADA 1934;21(5):820-844. 25. Pashley DH. Dynamics of the pulpo-dentin complex. Crit Rev Oral Biol Med 1996;7(2):104-133. 26. Braennstroem M, Astroem A. A study on the mechanism of pain elicited from the dentin. J Dent Res 1964;43:619-625. 27. Absi EG, Addy M, Adams D. Dentine hypersensitivity. A study of the patency of dentinal tubules in sensitive and non-sensitive cervical dentine. J Clin Periodontol 1987;14(5):280-284. 28. Chidchuangchai W, Vongsavan N, Matthews B. Sensory transduction mechanisms responsible for pain caused by cold stimulation of dentine in man. Arch Oral Biol 2007;52(2):154-160. 29. Loveren Cv. Exposed cervical dentin and dentin hypersensitivity summary of the discussion and recommendations. Clin Oral Investig 2013;17 Suppl 1(Suppl 1):S73-76. 30. Stauffacher S, Lussi A, Nietzsche S, Neuhaus KW, Eick S. Bacterial invasion into radicular dentine-an in vitro study. Clin Oral Investig 2017;21(5):1743-1752. 31. Love RM, Jenkinson HF. Invasion of dentinal tubules by oral bacteria. Crit Rev Oral Biol Med 2002;13(2):171-183. 32. Brannstrom M. The cause of postrestorative sensitivity and its prevention. J Endod 1986;12(10):475-481. 33. Brannstrom M. Dentin and pulp in restorative dentistry. J Endod 1982;8(3):92. 34. Lin LM, Skribner JE, Gaengler P. Factors associated with endodontic treatment failures. J Endod 1992;18(12):625-627. 35. Moraschini V, da Costa LS, Dos Santos GO. Effectiveness for dentin hypersensitivity treatment of non-carious cervical lesions: A meta-analysis. Clin Oral Investig 2018;22(2):617-631. 36. Pierote JJA, Prieto LT, Dias C, CÂmara JVF, Lima D, Aguiar FHB, et al. Effects of desensitizing products on the reduction of pain sensitivity caused by in-office tooth bleaching: A 24-week follow-up. J Appl Oral Sci 2020;28:e20190755. 37. Saraç D, Külünk S, Saraç YS, Karakas O. Effect of fluoride-containing desensitizing agents on the bond strength of resin-based cements to dentin. J Appl Oral Sci 2009;17(5):495-500. 38. Abuzinadah SH, Alhaddad AJ. A randomized clinical trial of dentin hypersensitivity reduction over one month after a single topical application of comparable materials. Sci Rep 2021;11(1):6793. 39. Hajizadeh H, Nemati-Karimooy A, Majidinia S, Moeintaghavi A, Ghavamnasiri M. Comparing the effect of a desensitizing material and a self-etch adhesive on dentin sensitivity after periodontal surgery: A randomized clinical trial. Restor Dent Endod 2017;42(3):168-175. 40. Sato M, Miyazaki M. Comparison of depth of dentin etching and resin infiltration with single-step adhesive systems. J. Dent. 2005;33(6):475-484. 41. Shabbir S, Ahmed S, Zaidi SJA, Riaz S, Sarwar H, Taqi M, et al. Efficacy of seventh generation bonding agents as desensitizers in patients with dentin hypersensitivity: A randomized clinical trial. BMC Oral Health 2024;24(1):562. 42. Kim HJ, Oh S, Kwon J, Choi KK, Jang JH, Kim DS. Desensitizing efficacy of a universal dentin adhesive containing mesoporous bioactive glass on dentin hypersensitivity: A randomized clinical trial with a split-mouth model. Sci Rep 2024;14(1):13926. 43. Sanad M, Shekidef MH. The effect of vitality and dentin depth on resin tags length of resin-dentin interface in dogs' teeth. Open Vet J 2019;9(2):126-132. 44. Burke FJT, Malik R, McHugh S, Crisp RJ, Lamb JJ. Treatment of dentinal hypersensitivity using a dentine bonding system. Int. Dent. J. 2000;50(5):283-288. 45. Petrović D, Galić D, Seifert D, Lešić N, Smolić M. Evaluation of bioactive glass treatment for dentin hypersensitivity: A systematic review. Biomedicines 2023;11(7). 46. Shah S, Shivakumar A, Khot O, Patil C, Hosmani N. Efficacy of novamin- and pro-argin-containing desensitizing dentifrices on occlusion of dentinal tubules. Dent. Hypotheses 2017;8(4). 47. do Nascimento Santos JV, de Moraes PWS, Pereira MN, Costa Leite JV, Magalhães GAP, Capehart K, et al. Bioactive glass products for the treatment of dentin hypersensitivity: A scoping review. Clin Oral Investig 2025;29(10):464. 48. Mneimne M, Hill RG, Bushby AJ, Brauer DS. High phosphate content significantly increases apatite formation of fluoride-containing bioactive glasses. Acta Biomater 2011;7(4):1827-1834. 49. Thomas NG, Junior FGdS, Ninan N, Anil S, Raju RS, Varghese N, et al. Bioglass in dentistry: A comprehensive review of current applications and innovative frontiers. J. Dent. 2025;162:106017. 50. Limeback H, Enax J, Meyer F. Clinical evidence of biomimetic hydroxyapatite in oral care products for reducing dentin hypersensitivity: An updated systematic review and meta-analysis. Biomimetics (Basel) 2023;8(1). 51. Arnold WH, Prange M, Naumova EA. Effectiveness of various toothpastes on dentine tubule occlusion. J Dent 2015;43(4):440-449. 52. Matsuura T, Mae M, Ohira M, Mihara Y, Yamashita Y, Sugimoto K, et al. The efficacy of a novel zinc-containing desensitizer caredyne shield for cervical dentin hypersensitivity: A pilot randomized controlled trial. BMC Oral Health 2022;22(1):294. 53. Kumagai T, Kashiwamura H, Katsumata M, Ozaki M. Verification of antibacterial activity to enamel surfaces of new type of surface coating. Pediatr. Dent. J. 2021;31(1):86-91. 54. Matsuura T, Mae M, Ohira M, Yamashita Y, Nakazono A, Sugimoto K, et al. The efficacy of the novel zinc-containing desensitizer caredyne shield on dentin hypersensitivity: A study protocol for a pilot randomized controlled trial. Trials 2020;21(1):464. 55. Lodha E, Hamba H, Nakashima S, Sadr A, Nikaido T, Tagami J. Effect of different desensitizers on inhibition of bovine dentin demineralization: Micro-computed tomography assessment. Eur. J. Oral Sci. 2014;122(6):404-410. 56. Xia W, Qin T, Suska F, Engqvist H. Bioactive spheres: The way of treating dentin hypersensitivity. ACS Biomater. Sci. Eng. 2016;2(5):734-740. 57. Chen WC, Chen CH, Kung JC, Hsiao YC, Shih CJ, Chien CS. Phosphorus effects of mesoporous bioactive glass on occlude exposed dentin. Materials 2013;6:5335-5351. 58. Jeon MJ, Park JW, Seo DG. Intratubular crystal formation in the exposed dentin from nano-sized calcium silicate for dentin hypersensitivity treatment. Sci. Rep. 2023;13(1):14243. 59. Deng M, Wen H-L, Dong X-L, Li F, Xu X, Li H, et al. Effects of 45s5 bioglass on surface properties of dental enamel subjected to 35% hydrogen peroxide. Int. J. Oral Sci. 2013;5(2):103-110. 60. Poggio C, Lombardini M, Vigorelli P, Colombo M, Chiesa M. The role of different toothpastes on preventing dentin erosion: An sem and afm study®. Scanning 2014;36(3):301-310. 61. Hill RG, Chen X, Gillam DG. In vitro ability of a novel nanohydroxyapatite oral rinse to occlude dentine tubules. Int J Dent 2015;2015:153284. 62. Mahmoodi B, Goggin P, Fowler C, Cook RB. Quantitative assessment of dentine mineralization and tubule occlusion by novamin and stannous fluoride using serial block face scanning electron microscopy. J Biomed Mater Res B Appl Biomater 2021;109(5):717-722. 63. Yan Y, Guan Y, Luo L, Lu B, Chen F, Jiang B. Effects of immunoglobulin y-loaded amorphous calcium phosphate on dentinal tubules occlusion and antibacterial activity. Front Bioeng Biotechnol 2022;10:921336. 64. Joshi S, Gowda AS, Joshi C. Comparative evaluation of novamin desensitizer and gluma desensitizer on dentinal tubule occlusion: A scanning electron microscopic study. J Periodontal Implant Sci 2013;43(6):269-275. 65. Kulal R, Jayanti I, Sambashivaiah S, Bilchodmath S. An in-vitro comparison of nano hydroxyapatite, novamin and proargin desensitizing toothpastes - a sem study. J Clin Diagn Res 2016;10(10):ZC51-ZC54. 66. Li L, Pan H, Tao J, Xu X, Mao C, Gu X, et al. Repair of enamel by using hydroxyapatite nanoparticles as the building blocks. J. Mater. Chem. 2008;18:4079-4084. 67. Amaechi BT, AbdulAzees PA, Alshareif DO, Shehata MA, Lima PPdCS, Abdollahi A, et al. Comparative efficacy of a hydroxyapatite and a fluoride toothpaste for prevention and remineralization of dental caries in children. BDJ Open 2019;5(1):18. 68. Ehlers V, Reuter AK, Kehl EB, Enax J, Meyer F, Schlecht J, et al. Efficacy of a toothpaste based on microcrystalline hydroxyapatite on children with hypersensitivity caused by mih: A randomised controlled trial. Oral Health Prev Dent 2021;19:647-658. 69. Pajor K, Pajchel L, Kolmas J. Hydroxyapatite and fluorapatite in conservative dentistry and oral implantology-a review. Materials (Basel) 2019;12(17). 70. Epple M, Enax J, Meyer F. Prevention of caries and dental erosion by fluorides-a critical discussion based on physico-chemical data and principles. Dent J (Basel) 2022;10(1). 71. Petersson LG. The role of fluoride in the preventive management of dentin hypersensitivity and root caries. Clin Oral Investig 2013;17 Suppl 1(Suppl 1):S63-71. 72. Elkassas D. Degree of dentinal tubules occlusion using different occluding and sealing technologies. Egypt. Dent. J. 2016;62:89-98. 73. Baik A, Alamoudi N, El-Housseiny A, Altuwirqi A. Fluoride varnishes for preventing occlusal dental caries: A review. Dent J (Basel) 2021;9(6). 74. Piszko PJ, Piszko A, Kiryk J, Lubojański A, Dobrzyński W, Wiglusz RJ, et al. The influence of fluoride gels on the physicochemical properties of tooth tissues and dental materials-a systematic review. Gels 2024;10(2). 75. Seyedakhavan P, Sayahpour S, Momeni H, Kharazi MJ. Effect of fluoride gel and foam on salivary fluoride concentration. J Res Dent Maxillofac Sci 2017;2(2):16. 76. Aldrees AM, AlBeshri SS, AlSanie IS, Alsarra IA. Assessment of fluoride concentrations in commercially available mouthrinses in central saudi arabia. Saudi Med J 2014;35(10):1278-1282. 77. Dagher A, Hannan N. Mouthwash: More harm than good? Br. Dent. J. 2019;226(4):240-240. 78. Walsh T, Worthington HV, Glenny AM, Marinho VC, Jeroncic A. Fluoride toothpastes of different concentrations for preventing dental caries. Cochrane Database Syst Rev 2019;3(3):Cd007868. 79. Grimm JR, Renteria C, Mukhopadhyay S, Devaraj A, Arola DD. Stratification of fluoride uptake among enamel crystals with age elucidated by atom probe tomography. Commun. Mater. 2024;5(1):270. 80. Everett ET. Fluoride's effects on the formation of teeth and bones, and the influence of genetics. J Dent Res 2011;90(5):552-560. 81. Dharmaratne RW. Exploring the role of excess fluoride in chronic kidney disease: A review. Hum Exp Toxicol 2019;38(3):269-279. 82. Death C, Coulson G, Kierdorf U, Kierdorf H, Ploeg R, Firestone S, et al. Chronic excess fluoride uptake contributes to degenerative joint disease (djd): Evidence from six marsupial species. Ecotoxicol Environ Saf 2018;162:383-390. 83. Dewan H, Sayed ME, Alqahtani NM, Alnajai T, Qasir A, Chohan H. The effect of commercially available desensitizers on bond strength following cementation of zirconia crowns using self-adhesive resin cement-an in vitro study. Materials (Basel) 2022;15(2). 84. Schüpbach P, Lutz F, Finger WJ. Closing of dentinal tubules by gluma desensitizer. Eur J Oral Sci 1997;105(5 Pt 1):414-421. 85. Kolker JL, Vargas MA, Armstrong SR, Dawson DV. Effect of desensitizing agents on dentin permeability and dentin tubule occlusion. J Adhes Dent 2002;4(3):211-221. 86. Sengun A, Buyukbas S, Hakki SS. Cytotoxic effects of dental desensitizers on human gingival fibroblasts. J Biomed Mater Res B Appl Biomater 2006;78(1):131-137. 87. Scheffel DL, Soares DG, Basso FG, de Souza Costa CA, Pashley D, Hebling J. Transdentinal cytotoxicity of glutaraldehyde on odontoblast-like cells. J Dent 2015;43(8):997-1006. 88. Arenholt-Bindslev D, Hörsted-Bindslev P, Philipsen HP. Toxic effects of two dental materials on human buccal epithelium in vitro and monkey buccal mucosa in vivo. Scand J Dent Res 1987;95(6):467-474. 89. de Assis Cde A, Antoniazzi RP, Zanatta FB, Rösing CK. Efficacy of gluma desensitizer on dentin hypersensitivity in periodontally treated patients. Braz Oral Res 2006;20(3):252-256. 90. Narra M, Anumula L, Chinni SK, Govula K, Sannapureddy S, Nagella K. Efficacy and durability of two desensitizing agents on dentinal tubule occlusion: An in vitro study. Cureus 2024;16(11):e74189. 91. Sharma S, Shetty NJ, Uppoor A. Evaluation of the clinical efficacy of potassium nitrate desensitizing mouthwash and a toothpaste in the treatment of dentinal hypersensitivity. J Clin Exp Dent 2012;4(1):e28-33. 92. Orchardson R, Gillam DG. The efficacy of potassium salts as agents for treating dentin hypersensitivity. J Orofac Pain 2000;14(1):9-19. 93. Poulsen S, Errboe M, Lescay Mevil Y, Glenny AM. Potassium containing toothpastes for dentine hypersensitivity. Cochrane Database Syst Rev 2006;2006(3):Cd001476. 94. Rahardjo A, Nasia A, Adiatman M, Maharani D. Efficacy of a toothpaste containing 5% potassium nitrate in desensitizing dentin hypersensitivity. Asian J. Pharm. Clin. Res. 2016;9:345-347. 95. James JM, Puranik MP, Sowmya KR. Dentinal tubule occluding effect of potassium nitrate in varied forms, frequencies and duration: An in vitro sem analysis. J Clin Diagn Res 2017;11(8):ZC06-ZC08. 96. Sen S. Comparative desensitizing effect of a toothpaste & mouthwash- containing potassium nitrate: An in vivo & in vitro scanning electron microscopic study. Adv. Dent. Oral Health 2018;8(5). 97. Pinto SC, Pochapski MT, Wambier DS, Pilatti GL, Santos FA. In vitro and in vivo analyses of the effects of desensitizing agents on dentin permeability and dentinal tubule occlusion. J Oral Sci 2010;52(1):23-32. 98. Behniafar B, Noori F, Chiniforoush N, Raee A. The effect of lasers in occlusion of dentinal tubules and reducing dentinal hypersensitivity, a scoping review. BMC Oral Health 2024;24(1):1407. 99. Ramareddy V, Kerbage C. An sem study on the effect of 9.3-µm co2 laser on dentinal tubules for hypersensitivity treatment. Lasers Med. Sci. 2024;39(1):200. 100. Asnaashari M, Moeini M. Effectiveness of lasers in the treatment of dentin hypersensitivity. J Lasers Med Sci 2013;4(1):1-7. 101. Lopes AO, de Paula Eduardo C, Aranha ACC. Evaluation of different treatment protocols for dentin hypersensitivity: An 18-month randomized clinical trial. Lasers Med Sci 2017;32(5):1023-1030. 102. Marmar L, Alhouri N, Hamadah O, Hamid T. Evaluation of the effect of diode laser used for dental desensitization on dentin shear bond strength of resin cement. Journal of Stomatology 2024;77:237-242. 103. Lin CP, Wang YL, Shen LJ, Lin CP. The dentin permeability of anti-inflammatory and antibacterial drugs: In vitro study. J Formos Med Assoc 2019;118(4):828-832. 104. Siekkinen M, Engblom M, Hupa L. Impact of solution ph (5–9) and dissolution products on in vitro behaviour of the bioactive glass s53p4. J. Non-Cryst. Solids: X 2023;20:100199. 105. Prati C, Montebugnoli L, Suppa P, Valdrè G, Mongiorgi R. Permeability and morphology of dentin after erosion induced by acidic drinks. J Periodontol 2003;74(4):428-436. 106. Merchant VA, Livingston MJ, Pashley DH. Dentin permeation: Comparison of diffusion with filtration. J Dent Res 1977;56(10):1161-1164. 107. Heyeraas KJ, Berggreen E. Interstitial fluid pressure in normal and inflamed pulp. Crit Rev Oral Biol Med 1999;10(3):328-336. 108. Conceicao J, Adeoye O, Cabral-Marques HM, Lobo JMS. Cyclodextrins as drug carriers in pharmaceutical technology: The state of the art. Curr Pharm Des 2018;24(13):1405-1433. 109. Stojanov M, Larsen KL. Cetirizine release from cyclodextrin formulated compressed chewing gum. Drug Dev Ind Pharm 2012;38(9):1061-1067. 110. Baranauskaite J, Kopustinskiene DM, Bernatoniene J. Impact of gelatin supplemented with gum arabic, tween 20, and beta-cyclodextrin on the microencapsulation of turkish oregano extract. Molecules 2019;24(1):176. 111. Loftsson T, Leeves N, Bjornsdottir B, Duffy L, Masson M. Effect of cyclodextrins and polymers on triclosan availability and substantivity in toothpastes in vivo. J Pharm Sci 1999;88(12):1254-1258. 112. Gharib R, Greige-Gerges H, Fourmentin S, Charcosset C, Auezova L. Liposomes incorporating cyclodextrin-drug inclusion complexes: Current state of knowledge. Carbohydr Polym 2015;129:175-186. 113. Ryzhakov A, Do Thi T, Stappaerts J, Bertoletti L, Kimpe K, Sa Couto AR, et al. Self-assembly of cyclodextrins and their complexes in aqueous solutions. J Pharm Sci 2016;105(9):2556-2569. 114. Maeso MH, González SP, Bravo-Díaz C, González-Romero E. Effects of α-, β- and γ-cyclodextrins on the critical micelle concentration of sodium dodecyl sulfate micelles. Colloids Surf., A 2004;249(1-3):29-33. 115. Haller J, Kaatze U. Complexation versus micelle formation: Α-cyclodextrin+n-decyltrimethylammonium bromide aqueous solutions. Chem. Phys. Lett. 2008;463(1-3):94-98. 116. Chen Y, Huang Y, Qin D, Liu W, Song C, Lou K, et al. Beta-cyclodextrin-based inclusion complexation bridged biodegradable self-assembly macromolecular micelle for the delivery of paclitaxel. PLoS One 2016;11(3):e0150877. 117. Guo B, Xu D, Liu X, Liao C, Li S, Huang Z, et al. Characterization and cytotoxicity of plga nanoparticles loaded with formononetin cyclodextrin complex. J. Drug Delivery Sci. Technol. 2017;41:375-383. 118. Vega E, Egea MA, Calpena AC, Espina M, Garcia ML. Role of hydroxypropyl-beta-cyclodextrin on freeze-dried and gamma-irradiated plga and plga-peg diblock copolymer nanospheres for ophthalmic flurbiprofen delivery. Int J Nanomedicine 2012;7:1357-1371. 119. Wang M, Jin Z, Liu L, Wang Z, Li F, Sun W, et al. Inhibition of cyclodextrins on the activity of α-amylase. J. Inclusion Phenom. Macrocyclic Chem. 2018;90(3-4):351-356. 120. Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins: Basic science and product development. J. Pharm. Pharmacol. 2010;62(11):1607-1621. 121. Alonso L, Cuesta P, Fontecha J, Juarez M, Gilliland SE. Use of beta-cyclodextrin to decrease the level of cholesterol in milk fat. J Dairy Sci 2009;92(3):863-869. 122. Alonso L, Cuesta P, Gilliland SE. Effect of β-cyclodextrin on trans fats, cla, pufa, and phospholipids of milk fat: Method update. J. Am. Oil Chem. Soc. 2009;86(5):495-495. 123. Amar MJ, Kaler M, Courville AB, Shamburek R, Sampson M, Remaley AT. Randomized double blind clinical trial on the effect of oral alpha-cyclodextrin on serum lipids. Lipids Health Dis 2016;15(1):115. 124. Wagner EM, Jen KL, Artiss JD, Remaley AT. Dietary alpha-cyclodextrin lowers low-density lipoprotein cholesterol and alters plasma fatty acid profile in low-density lipoprotein receptor knockout mice on a high-fat diet. Metabolism 2008;57(8):1046-1051. 125. Comerford KB, Artiss JD, Jen KL, Karakas SE. The beneficial effects of alpha-cyclodextrin on blood lipids and weight loss in healthy humans. Obesity (Silver Spring) 2011;19(6):1200-1204. 126. Athanassiou G, Michaleas S, Lada-Chitiroglou E, Tsitsa T, Antoniadou-Vyza E. Antimicrobial activity of beta-lactam antibiotics against clinical pathogens after molecular inclusion in several cyclodextrins. A novel approach to bacterial resistance. J Pharm Pharmacol 2003;55(3):291-300. 127. Bojarova P, Kren V. Sugared biomaterial binding lectins: Achievements and perspectives. Biomater Sci 2016;4(8):1142-1160. 128. Liang H, Yuan Q, Vriesekoop F, Lv F. Effects of cyclodextrins on the antimicrobial activity of plant-derived essential oil compounds. Food Chem 2012;135(3):1020-1027. 129. Nava-Ortiz CA, Burillo G, Concheiro A, Bucio E, Matthijs N, Nelis H, et al. Cyclodextrin-functionalized biomaterials loaded with miconazole prevent candida albicans biofilm formation in vitro. Acta Biomater. 2010;6(4):1398-1404. 130. Macocinschi D, Filip D, Vlad S, Tuchilus CG, Cristian AF, Barboiu M. Polyurethane/beta-cyclodextrin/ciprofloxacin composite films for possible medical coatings with antibacterial properties. J Mater Chem B 2014;2(6):681-690. 131. Yamamoto N, Petroll MW, Cavanagh HD, Jester JV. Internalization of pseudomonas aeruginosa is mediated by lipid rafts in contact lens-wearing rabbit and cultured human corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 2005;46(4):1348-1355. 132. Campbell SM, Crowe SM, Mak J. Lipid rafts and hiv-1: From viral entry to assembly of progeny virions. J. Clin. Virol. 2001;22(3):217-227. 133. Miller MB, Bassler BL. Quorum sensing in bacteria. Annu. Rev. Microbiol. 2001;55:165-199. 134. Banerjee G, Ray AK. The talking language in some major gram-negative bacteria. Arch Microbiol 2016;198(6):489-499. 135. Hatt JK, Rather PN. Role of bacterial biofilms in urinary tract infections. Curr. Top. Microbiol. Immunol. 2008;322:163-192. 136. Marsh PD, Zaura E. Dental biofilm: Ecological interactions in health and disease. J Clin Periodontol 2017;44 Suppl 18:S12-S22. 137. Zaas DW, Duncan M, Rae Wright J, Abraham SN. The role of lipid rafts in the pathogenesis of bacterial infections. Biochim Biophys Acta 2005;1746(3):305-313. 138. Leclercq L. Interactions between cyclodextrins and cellular components: Towards greener medical applications? Beilstein J Org Chem 2016;12:2644-2662. 139. Mochida K, Kagita A, Matsui Y, Date Y. Effects of inorganic salts on the dissociation of a β-cyclodextrin complex with an azo dye in an aqueous solution. . Bull. Chem. Soc. Jap. 1973;46(12):3703–3707. 140. Mochida K, Kagita A, Matsui Y, Date Y. Nmr spectroscopy of cyclodextrin-inorganic anion systems. Bull. Chem. Soc. Jpn. 1997;70(9):535–541. 141. Sukhorukov GB, Volodkin DV, Günther AM, Petrov AI, Shenoy DB, Möhwald H. Porous calcium carbonate microparticles as templates for encapsulation of bioactive compounds. J. Mater. Chem. 2004;14(14):2073-2081. 142. Volodkin DV, Petrov AI, Prevot M, Sukhorukov GB. Matrix polyelectrolyte microcapsules: New system for macromolecule encapsulation. Langmuir 2004;20(8):3398-3406. 143. Zhang L, Zhu W, Lin Q, Han J, Jiang L, Zhang Y. Hydroxypropyl-beta-cyclodextrin functionalized calcium carbonate microparticles as a potential carrier for enhancing oral delivery of water-insoluble drugs. Int J Nanomedicine 2015;10:3291-3302. 144. Wu K, Chen F, Liu Y, Luo J. Preparation and properties of β-cyclodextrins polymer used as calcium carbonate scale inhibitor containing fluorescent groups. Res. Chem. Intermed. 2014;41(10):7617-7630. 145. Lakkakula JR, Kurapati R, Tynga I, Abrahamse H, Raichur Ashok M, Maçedo Krause RW. Cyclodextrin grafted calcium carbonate vaterite particles: Efficient system for tailored release of hydrophobic anticancer or hormone drugs. RSC Adv. 2016;6(106):104537-104548. 146. Kurapati R, Raichur AM. Composite cyclodextrin–calcium carbonate porous microparticles and modified multilayer capsules: Novel carriers for encapsulation of hydrophobic drugs. J Mater Chem B 2013;1(25):3175-3184. 147. Derakhshanian V, Banerjee S. Cyclodextrin inhibits calcium carbonate crystallization and scaling. Ind. Eng. Chem. Res. 2012;51(11):4463-4465. 148. Viswanathan K, Lee YC, Fang YS. The synthesis and characterizations of calcium phosphate nanoparticles via β-cyclodextrin, poly(oxyethylene)5nonyl phenol ether and cyclohexane medium. J. Chin. Chem. Soc. 2013;60(12):1411-1414. 149. Trajano VCC, Costa KJR, Lanza CRM, Sinisterra RD, Cortes ME. Osteogenic activity of cyclodextrin-encapsulated doxycycline in a calcium phosphate pcl and plga composite. Mater Sci Eng C Mater Biol Appl 2016;64:370-375. 150. Jacobsen P, Nielsen JL, Juhl M, Theilgaard N, Larsen K. Grafting cyclodextrins to calcium phosphate ceramics for biomedical applications. J. Incl. Phenom. Macrocycl. Chem. 2011;72(1-2):173-181. 151. Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R. Biodegradable long-circulating polymeric nanospheres. Science 1994;263(5153):1600-1603. 152. Hansen PL, Cohen JA, Podgornik R, Parsegian VA. Osmotic properties of poly(ethylene glycols): Quantitative features of brush and bulk scaling laws. Biophys. J. 2003;84(1):350-355. 153. Levchenko TS, Rammohan R, Lukyanov AN, Whiteman KR, Torchilin VP. Liposome clearance in mice: The effect of a separate and combined presence of surface charge and polymer coating. Int J Pharm 2002;240(1-2):95-102. 154. Gref R, Domb A, Quellec P, Blunk T, Müller RH, Verbavatz JM, et al. The controlled intravenous delivery of drugs using peg-coated sterically stabilized nanospheres. Adv Drug Deliv Rev 1995;16(2-3):215-233. 155. Sharpe M, Easthope SE, Keating GM, Lamb HM. Polyethylene glycol-liposomal doxorubicin: A review of its use in the management of solid and haematological malignancies and aids-related kaposi's sarcoma. Drugs 2002;62(14):2089-2126. 156. Veronese FM, Schiavon O, Pasut G, Mendichi R, Andersson L, Tsirk A, et al. Peg-doxorubicin conjugates: Influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity. Bioconjug Chem 2005;16(4):775-784. 157. Baumann A, Piel I, Hucke F, Sandmann S, Hetzel T, Schwarz T. Pharmacokinetics, excretion, distribution, and metabolism of 60-kda polyethylene glycol used in bay 94-9027 in rats and its value for human prediction. Eur J Pharm Sci 2019;130:11-20. 158. Baumann A, Tuerck D, Prabhu S, Dickmann L, Sims J. Pharmacokinetics, metabolism and distribution of pegs and pegylated proteins: Quo vadis? Drug Discov Today 2014;19(10):1623-1631. 159. Park KD, Kim YS, Han DK, Kim YH, Lee EH, Suh H, et al. Bacterial adhesion on peg modified polyurethane surfaces. Biomaterials 1998;19(7-9):851-859. 160. Shi H, Liu H, Luan S, Shi D, Yan S, Liu C, et al. Effect of polyethylene glycol on the antibacterial properties of polyurethane/carbon nanotube electrospun nanofibers. RSC Adv. 2016;6(23):19238-19244. 161. Rafienia M, Zarinmehr B, Poursamar SA, Bonakdar S, Ghavami M, Janmaleki M. Coated urinary catheter by peg/pva/gentamicin with drug delivery capability against hospital infection. Iran. Polym. J. 2012;22(2):75-83. 162. Tailly T, MacPhee RA, Cadieux P, Burton JP, Dalsin J, Wattengel C, et al. Evaluation of polyethylene glycol-based antimicrobial coatings on urinary catheters in the prevention of escherichia coli infections in a rabbit model. J Endourol 2021;35(1):116-121. 163. Peng L, Chang L, Liu X, Lin J, Liu H, Han B, et al. Antibacterial property of a polyethylene glycol-grafted dental material. ACS Appl Mater Interfaces 2017;9(21):17688-17692. 164. Grischke J, Eberhard J, Stiesch M. Antimicrobial dental implant functionalization strategies -a systematic review. Dent Mater J 2016;35(4):545-558. 165. Buxadera-Palomero J, Canal C, Torrent-Camarero S, Garrido B, Javier-Gil F, Rodriguez D. Antifouling coatings for dental implants: Polyethylene glycol-like coatings on titanium by plasma polymerization. Biointerphases 2015;10(2):029505. 166. Chirife J, Herszage L, Joseph A, Bozzini JP, Leardini N, Kohn ES. In vitro antibacterial activity of concentrated polyethylene glycol 400 solutions. Antimicrob Agents Chemother 1983;24(3):409-412. 167. Cox CS. Bacterial survival in suspension in polyethylene glycol solutions. J Gen Microbiol 1966;45(2):275-281. 168. Nalawade TM, Bhat K, Sogi SH. Bactericidal activity of propylene glycol, glycerine, polyethylene glycol 400, and polyethylene glycol 1000 against selected microorganisms. J Int Soc Prev Community Dent 2015;5(2):114-119. 169. Wojtyniak K, Szajewska H. Systematic review: Probiotics for functional constipation in children. Eur J Pediatr 2017;176(9):1155-1162. 170. Russo M, Giugliano FP, Quitadamo P, Mancusi V, Miele E, Staiano A. Efficacy of a mixture of probiotic agents as complementary therapy for chronic functional constipation in childhood. Ital J Pediatr 2017;43(1):24. 171. Ray W, Puvathingal J. The effect of polyethylene glycol on the growth and dissolution rates of a crystalline protein at high salt concentration. Phosphoglucomutase. J. Biol. Chem. 1986;261(25):11544-11549. 172. Li F-J, Zhang S-D, Liang J-Z, Wang J-Z. Effect of polyethylene glycol on the crystallization and impact properties of polylactide-based blends. Polym. Adv. Technol. 2015;26(5):465-475. 173. Dong Y, Meng F. Effect of polyethylene glycol on crystal growth and photocatalytic activity of anatase tio2 single crystals. RSC Adv. 2020;10(21):12511-12518. 174. Liu S, Weng W, Li Z, Pan L, Cheng K, Song C, et al. Effect of peg amount in amorphous calcium phosphate on its crystallized products. J. Mater. Sci.: Mater. Med. 2009;20(1):359-363. 175. Danafar H, Khurana V. Preparation and characterization of pcl-peg-pcl polymersomes for delivery of clavulanic acid. Cogent Med. 2016;3(1). 176. Zhang J, Men K, Gu Y, Wang X, Gou M, Guo G, et al. Preparation of core cross-linked pcl-peg-pcl micelles for doxorubicin delivery in vitro. J Nanosci Nanotechnol 2011;11(6):5054-5061. 177. Fleet M, Liu X. Accommodation of the carbonate ion in apatite: An ftir and x-ray structure study of crystals synthesized at 2-4 gpa. Am. Mineral. 2004;89. 178. Sudarsanan K, Young RA. Structure of strontium hydroxide phosphate, sr5(po4)3oh. Acta Crystallogr. Sect. B Struct. Sci. 1972;28(12):3668-3670. 179. Boudjada A, Masse R, Guitel JC. Structure cristalline de l'orthophosphate monoacide de strontium:Srhpo4α: Forme triclinique. Acta Crystallogr. Sect. B Struct. Sci. 1978;34(9):2692-2695. 180. Passos AD, Tziafas D, Mouza A, Paras S. Computational modelling for efficient transdentinal drug delivery. Fluids 2017;3:4. 181. Genari B, Leitune VC, Jornada DS, Camassola M, Pohlmann AR, Guterres SS, et al. Effect of indomethacin-loaded nanocapsules incorporation in a dentin adhesive resin. Clin Oral Investig 2017;21(1):437-446. 182. Calt S, Serper A, Ozçelik B, Dalat MD. Ph changes and calcium ion diffusion from calcium hydroxide dressing materials through root dentin. J Endod 1999;25(5):329-331. 183. Sayin TC, Serper A, Cehreli ZC, Kalayci S. Calcium loss from root canal dentin following edta, egta, edtac, and tetracycline-hcl treatment with or without subsequent naocl irrigation. J Endod 2007;33(5):581-584. 184. Koutsi V, Noonan RG, Horner JA, Simpson MD, Matthews WG, Pashley DH. The effect of dentin depth on the permeability and ultrastructure of primary molars. Pediatr Dent 1994;16(1):29-35. 185. Pashley DH, Thompson SM, Stewart FP. Dentin permeability: Effects of temperature on hydraulic conductance. J Dent Res 1983;62(9):956-959. 186. Miyake N, Sato T, Maki Y. Effect of zeta potentials on bovine serum albumin adsorption to hydroxyapatite surfaces. Bull Tokyo Dent Coll 2013;54(2):97-101. 187. Weerkamp AH, Uyen HM, Busscher HJ. Effect of zeta potential and surface energy on bacterial adhesion to uncoated and saliva-coated human enamel and dentin. J Dent Res 1988;67(12):1483-1487. 188. Saeki K, Marshall GW, Gansky SA, Parkinson CR, Marshall SJ. Strontium effects on root dentin tubule occlusion and nanomechanical properties. Dent Mater 2016;32(2):240-251. 189. Gomes IC, Chevitarese O, de Almeida NS, Salles MR, Gomes GC. Diffusion of calcium through dentin. J Endod 1996;22(11):590-595. 190. Bertassoni LE, Stankoska K, Swain MV. Insights into the structure and composition of the peritubular dentin organic matrix and the lamina limitans. Micron 2012;43(2-3):229-236. 191. Song Y, Zhang F, Linhardt RJ. Glycosaminoglycans. Adv Exp Med Biol 2021;1325:103-116. 192. Hunter GK, Wong KS, Kim JJ. Binding of calcium to glycosaminoglycans: An equilibrium dialysis study. Arch Biochem Biophys 1988;260(1):161-167. 193. Sobczak AIS, Pitt SJ, Stewart AJ. Influence of zinc on glycosaminoglycan neutralisation during coagulation. Metallomics 2018;10(9):1180-1190. 194. Dechichi P, Biffi JC, Moura CC, de Ameida AW. A model of the early mineralization process of mantle dentin. Micron 2007;38(5):486-491. 195. Sionkowski P, Bełdowski P, Kruszewska N, Weber P, Marciniak B, Domino K. Effect of ion and binding site on the conformation of chosen glycosaminoglycans at the albumin surface. Entropy 2022;24:811. 196. Otake T, Ishii T, Ishii T, Nakahara M, Nakamura R. Changes in otolith strontium:Calcium ratios in metamorphosing conger myrisaster leptocephali. Mar. Biol. 1997;128(4):565-572. 197. Scott JE, Thomlinson AM. The structure of interfibrillar proteoglycan bridges (shape modules') in extracellular matrix of fibrous connective tissues and their stability in various chemical environments. J Anat 1998;192 ( Pt 3)(Pt 3):391-405. 198. Leung N, Harper RA, Zhu B, Shelton RM, Landini G, Sui T. 4d microstructural changes in dentinal tubules during acid demineralisation. Dent. Mater. 2021;37(11):1714-1723. 199. Hanks CT, Wataha JC, Parsell RR, Strawn SE, Fat JC. Permeability of biological and synthetic molecules through dentine. Journal of oral rehabilitation 1994;21(4):475-487. 200. Prochowicz D, Kornowicz A, Lewiński J. Interactions of native cyclodextrins with metal ions and inorganic nanoparticles: Fertile landscape for chemistry and materials science. Chem Rev 2017;117(22):13461-13501. 201. Domb D, Shende P. Cyclodextrin-transition metal complexes emerge as promising tools for modulating peptide function. J. Mol. Liq. 2025;417:126621. 202. Norkus E. Metal ion complexes with native cyclodextrins. An overview. J. Inclusion Phenom. Macrocyclic Chem. 2009;65:237-248. 203. Hodorowicz M, Sternal M, Jurowska A, Szklarzewicz J. Structures of ca and sr salts with [w(cn)6(bpy)]− ion. Comparative studies to alkali metal salts analogues. J. Mol. Struct. 2023;1284:135374. 204. Bowen RL, Schumacher GE, Giuseppetti AA, Guttman CM, Carey CM. Adhesive bonding to dentin improved by polymerizable cyclodextrin derivatives. J Res Natl Inst Stand Technol 2009;114(1):11-20. 205. Chen AXY, Kesharwani T, Wu Y, Stern CL, Đorđević L, Wu H, et al. Site-selective c–h functionalization in a cyclodextrin metal-organic framework. Chem 2024;10(1):234-249. 206. Ogawa N, Takahashi C, Yamamoto H. Physicochemical characterization of cyclodextrin–drug interactions in the solid state and the effect of water on these interactions. J. Pharm. Sci. 2015;104(3):942-954. 207. Hamley IW, Castelletto V. Cyclodextrin-induced suppression of the crystallization of low-molar-mass poly(ethylene glycol). ACS Polym. Au 2024;4(4):266-272. 208. Liu M, Higashi K, Ueda K, Moribe K. Supersaturation maintenance of carvedilol and chlorthalidone by cyclodextrin derivatives: Pronounced crystallization inhibition ability of methylated cyclodextrin. Int. J. Pharm. 2023;637:122876. 209. Iohara D, Anraku M, Uekama K, Hirayama F. Modification of drug crystallization by cyclodextrins in pre-formulation study. Chem Pharm Bull (Tokyo) 2019;67(9):915-920. 210. Krūkle-Bērziņa K, Mishnev A. Never-ending story: New cyclodextrin-based metal–organic framework crystal structures obtained using different crystallization methods. ACS Omega 2023;8(50):48221-48232. 211. Roy I, Stoddart JF. Cyclodextrin metal–organic frameworks and their applications. Acc. Chem. Res. 2021;54(6):1440-1453. 212. Wang Q-J, Zhao G, Zhang C-Y. Cyclodextrin and its derivatives enhance protein crystallization by grafted on crystallization plates. J. Cryst. Growth 2020;536:125591. 213. Nelumdeniya NRM, Ranatunga U. Complex forming behaviour of α, β and γ-cyclodextrins with varying size probe particles in silico. Ceylon J. Sci. 2021;50:329. 214. Terauchi M, Tamura A, Arisaka Y, Masuda H, Yoda T, Yui N. Cyclodextrin-based supramolecular complexes of osteoinductive agents for dental tissue regeneration. Pharmaceutics 2021;13(2). 215. De la cruz-Rocha ER, Parada-Sanchez MT, Arboleda-Toro D, Cañas-Gutierrez AI. Pulp regeneration in necrotic teeth based on functionalized scaffolds: A review of clinical and experimental strategies. Curr Oral Health Rep 2025;12(1):7. 216. Ballikaya E, Babadag S, Tüzün I, San Keskin NO, Çelebi-Saltik B. Proanthocyanidin/β-cyclodextrin inclusion complex in electrospun polylactic acid nanofibers: Preparation, characterization, and effects on dental pulp stem cells. ACS Appl. Polym. Mater. 2024;6(5):2889-2901. 217. Daghrery A, Aytac Z, Dubey N, Mei L, Schwendeman A, Bottino MC. Electrospinning of dexamethasone/cyclodextrin inclusion complex polymer fibers for dental pulp therapy. Colloids Surf., B 2020;191:111011. 218. Tootla S, de Souza Araújo IJ, Daghrery A, Bottino MC. Dexamethasone/β-cyclodextrin inclusion complex hydrogel for vital pulp therapy. Odontology 2025. 219. Spagnuolo G, De Luca I, Iaculli F, Barbato E, Valletta A, Calarco A, et al. Regeneration of dentin-pulp complex: Effect of calcium-based materials on hdpscs differentiation and gene expression. Dent Mater 2023;39(5):485-491. 220. Rathinam E, Govindarajan S, Rajasekharan S, Declercq H, Elewaut D, De Coster P, et al. The calcium dynamics of human dental pulp stem cells stimulated with tricalcium silicate-based cements determine their differentiation and mineralization outcome. Sci. Rep. 2021;11(1):645. 221. Bakr MM, Shamel M, Raafat SN, Love RM, Al-Ankily MM. Effect of pulp capping materials on odontogenic differentiation of human dental pulp stem cells: An in vitro study. Clin Exp Dent Res 2024;10(1):e816. 222. Yamamura H, Hagiwara T, Hayashi Y, Osawa K, Kato H, Katsu T, et al. Antibacterial activity of membrane-permeabilizing bactericidal cyclodextrin derivatives. ACS Omega 2021;6(47):31831-31842. 223. Braga SS. Cyclodextrins as multi-functional ingredients in dentistry. Pharmaceutics 2023;15(9). 224. Bhargava S, Agrawal GP. Preparation & characterization of solid inclusion complex of cefpodoxime proxetil with beta-cyclodextrin. Curr Drug Deliv 2008;5(1):1-6. 225. Jeong D, Joo SW, Shinde VV, Cho E, Jung S. Carbohydrate-based host-guest complexation of hydrophobic antibiotics for the enhancement of antibacterial activity. Molecules 2017;22(8). 226. Thomsen H, Benkovics G, Fenyvesi É, Farewell A, Malanga M, Ericson MB. Delivery of cyclodextrin polymers to bacterial biofilms — an exploratory study using rhodamine labelled cyclodextrins and multiphoton microscopy. Int. J. Pharm. 2017;531(2):650-657. 227. Berkl Z, Fekete-Kertész I, Buda K, Vaszita E, Fenyvesi É, Szente L, et al. Effect of cyclodextrins on the biofilm formation capacity of pseudomonas aeruginosa pao1. Molecules 2022;27(11). 228. Amjad Z, Zuhl R. The influence of polymer architecture on inhibition of amorphous calcium phosphate precipitation. Phosphorus Res. Bull. 2002;13:51-57. 229. Offermann LR, He JZ, Mank NJ, Booth WT, 2nd, Chruszcz M. Carboxylic acids in crystallization of macromolecules: Learning from successful crystallization experiments. J Struct Funct Genomics 2014;15(1):13-24. 230. Wada N, Kanamura K, Umegaki T. Effects of carboxylic acids on the crystallization of calcium carbonate. J. Colloid Interface Sci. 2001;233(1):65-72. 231. Kamitakahara M, Kawashita M, Kokubo T, Nakamura T. Effect of polyacrylic acid on the apatite formation of a bioactive ceramic in a simulated body fluid: Fundamental examination of the possibility of obtaining bioactive glass-ionomer cements for orthopaedic use. Biomaterials 2001;22(23):3191-3196. 232. Dethe MR, A P, Ahmed H, Agrawal M, Roy U, Alexander A. Pcl-peg copolymer based injectable thermosensitive hydrogels. J Control Release 2022;343:217-236. 233. Kurata S, Morishita K, Kawase T, Umemoto K. Cytotoxic effects of acrylic acid, methacrylic acid, their corresponding saturated carboxylic acids, hema, and hydroquinone on fibroblasts derived from human pulp. Dent Mater J 2012;31(2):219-225. 234. Lu Q, Pandya M, Rufaihah AJ, Rosa V, Tong HJ, Seliktar D, et al. Modulation of dental pulp stem cell odontogenesis in a tunable peg-fibrinogen hydrogel system. Stem Cells Int 2015;2015:525367. 235. Kim JE, Park S, Lee WS, Han J, Lim JW, Jeong S, et al. Enhanced osteogenesis of dental pulp stem cells in vitro induced by chitosan-peg-incorporated calcium phosphate cement. Polymers (Basel) 2021;13(14). 236. Falghoush A, Beyenal H, Besser TE, Omsland A, Call DR. Osmotic compounds enhance antibiotic efficacy against acinetobacter baumannii biofilm communities. Appl Environ Microbiol 2017;83(19). 237. Jayanetti M, Thambiliyagodage C, Liyanaarachchi H, Ekanayake G, Mendis A, Usgodaarachchi L. In vitro influence of peg functionalized zno–cuo nanocomposites on bacterial growth. Sci. Rep. 2024;14(1):1293. 238. Pompa-Monroy DA, Iglesias AL, Dastager SG, Thorat MN, Olivas-Sarabia A, Valdez-Castro R, et al. Comparative study of polycaprolactone electrospun fibers and casting films enriched with carbon and nitrogen sources and their potential use in water bioremediation. Membranes 2022;12(3):327. 239. Gratzl G, Walkner S, Hild S, Hassel AW, Weber H, Paulik C. Mechanistic approaches on the antibacterial activity of poly(acrylic acid) copolymers. Colloids Surf., B 2014;126. 240. Montastruc L, Azzaro-Pantel C, Biscans B, Cabassud M, Domenech S. A thermochemical approach for calcium phosphate precipitation modeling in a pellet reactor. Chem. Eng. J. 2003;94. 241. Ito A, Maekawa K, Tsutsumi S, Ikazaki F, Tateishi T. Solubility product of oh-carbonated hydroxyapatite. J Biomed Mater Res 1997;36(4):522-528. 242. Tung M, Eidelman N, Sieck B, Brown WE. Octacalcium phosphate solubility product from 4 to 37-degree-c. J. Res. Natl. Bur. Stand. 1988;93:613. 243. Crutchik D, Garrido JM. Struvite crystallization versus amorphous magnesium and calcium phosphate precipitation during the treatment of a saline industrial wastewater. Water Sci Technol 2011;64(12):2460-2467. 244. Lothenbach B, Xu B, Winnefeld F. Thermodynamic data for magnesium (potassium) phosphates. Appl. Geochem. 2019;111:104450. | - |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/102131 | - |
| dc.description.abstract | 牙本質小管的暴露是導致牙本質敏感症與牙髓細菌感染的關鍵因素。目前的臨床治療與居家保健的策略多依賴使用生物活性的材料,如生醫玻璃或鈣鹽等,透過離子釋放與沉積,達成牙本質小管封閉,然而,此類材料多需在極端酸性環境下作用才有較好的治療成效,這容易導致牙齒硬組織結構的去礦化,且或因離子擴散受限而僅能形成較為淺層且容易脫落的封填,難以達到持久的治療效果。本研究旨在釐清無機離子於牙本質小管內的滲透模式與其機制,並依據此,開發新型奈米載體系統,以實現在中性生理條件下較短反應時間的深層封填,並期望能同時具備抗菌或是誘導牙本質再生等多重功效。
首先,本研究透過人口外牙製備的離子滲透模型,經統計分析系統性探討了pH值、離子電荷與分子量等對牙本質小管滲透效率的影響(第一部分)。研究發現,環境pH值是調控離子傳輸的主導因子。在鹼性環境下,小管壁上的醣胺聚醣去質子化後帶有高密度負電荷,形成雙電層並強烈吸附鈣、鍶等二價陽離子,顯著阻礙其深層擴散;反之,酸性環境雖能促進滲透,卻伴隨脫礦風險。此外,各元素的族、分子量、電性與電量也對牙本質小管內的離子滲透具有顯著的選擇性,如分子量較小、帶電量接近電中性的鈉元素,存在各酸鹼條件下,最佳的滲透成效。這些發現確立了電荷屏蔽與中性操作環境作為開發下一代牙本質封填製劑的關鍵設計原則。 基於對於離子滲透的分析,已成功開發一系列攜帶離子的微脂體(Liposome)專利製劑,並證實奈米劑型遞送系統有利於牙本質內藥物遞送,但是這些天然磷脂基底的製劑仍需要較長的滲透與結晶時間,且微脂體並不具備抗菌成效,故本研究進一步開發攜帶離子的奈米載體系統,希望透過不同分子結構的引入,強化牙本質小管內的封填與殺菌應用成效。 因此,本研究的第二部分利用三種不同分子結構大小的環狀糊精(Cyclodextrins)作為奈米載體,透過其特殊的空腔結構與鈣、鍶離子形成近電中性的奈米複合物。此部分的實驗證實,α-環狀糊精複合物能有效規避小管壁的靜電阻力,在中性環境下深入小管達 40 微米並形成緻密的礦化封填,同時展現優異的細胞相容性、針對三種口腔病原菌的抑制能力與牙髓幹細胞的誘導分化能力。 為突破滲透深度的限制,本研究進一步探討了線性的聚乙二醇(Polyethylene glycol,PEG)與其衍生物作為離子載體的潛力,本研究選用五種分子量的PEG,搭配兩種官能基的修飾作為材料。研究顯示,低分子量 PEG 具備優異的滲透壓效應與低黏度特性,能攜帶鍶離子深入小管達 140 微米,遠高於現行研究所報導的封填深度。而雖引入丙烯酸(AAC)官能基可增強晶體調控與抗菌性,但也伴隨滲透深度降低與細胞毒性增加的權衡,證實低分子量且電中性的 PEG 為較佳的載體選擇。 總結而言,本論文透過基礎機制的釐清,闡明牙本質小管內的離子滲透模式,並成功開發了環狀糊精與PEG兩類奈米載體系統,克服了傳統材料依賴極端pH值的局限,並實現兼具快速滲透、深層礦化礦化、抗菌成效、並誘導活髓分化的複合治療模式,未來可提供暴露牙本質小管衍生疾病之科學依據,作為治療策略的重要參考。 | zh_TW |
| dc.description.abstract | The exposure of dentinal tubules is a critical factor leading to dentin hypersensitivity and pulpal bacterial infection. Current clinical treatments and home-care strategies primarily rely on bioactive materials, such as bioactive glass or calcium salts, to achieve tubule occlusion through ion release and deposition. However, these materials often require highly acidic environments to achieve optimal therapeutic efficacy, which poses a risk of demineralizing the tooth. Furthermore, limited ion diffusion often results in the formation of shallow and easily dislodged seals, making it hard to develop durable therapeutic effects. This study aims to elucidate the penetration modes and mechanisms of inorganic ions within dentinal tubules. Based on these findings, the study develops novel nanocarrier systems capable of achieving deep occlusion within relatively short reaction time under neutral pH conditions, while simultaneously providing multifunctional benefits such as antibacterial properties or the induction of dentin regeneration.
First, this study systematically investigated the effects of pH, ion charge, and molecular weight on dentinal tubule penetration using an ex vivo human dentin disc ion penetration model and statistical analysis (Part 1). The results indicated that environmental pH is the dominant factor that regulating ion transport. In alkaline environments, glycosaminoglycans on the tubule walls deprotonate and carry a high density of negative charges, forming an electric double layer that strongly adsorbs divalent cations, thereby significantly hindering their deep diffusion. Conversely, while acidic environments promote penetration, they are accompanied by the risk of demineralization. Additionally, the group, molecular weight and charge of elements showed significant selectivity regarding ion penetration within dentinal tubules. Therefore, sodium with smaller molecular weight and a charge closer to neutral demonstrated the best penetration efficacy across various pH conditions. These findings established charge shielding and neutral operating environments as key design principles for the development of next-generation dentin sealing agents. Although a series of patented ion-carrying liposome formulations were successfully developed based on this ion penetration analysis, confirming that nano-delivery systems facilitate intra-dentinal drug delivery, these natural phospholipid-based preparations require longer penetration and crystallization times, and liposomes lack intrinsic antibacterial properties. Consequently, this study further developed two types of polymer-based ion carrier systems, aiming to enhance tubule sealing and disinfection efficacy through molecular structure design. Therefore, the second part of this study utilized cyclodextrins (CDs) of three different molecular sizes as nanocarriers. Through their unique cavity structures, they formed near-neutral nanocomplexes with calcium and strontium ions. Results confirmed that α-cyclodextrin complexes effectively evaded the electrostatic resistance of the tubule walls, penetrating up to 40 μm into the tubules under neutral conditions to form occlusion. Simultaneously, they exhibited excellent cytocompatibility, inhibitory capabilities against three kinds of oral pathogens, and the ability to induce dental pulp stem cell differentiation. To further overcome the limitations of penetration depth, this study investigated the potential of linear polyethylene glycol (PEG) and its derivatives as ion carriers. Five molecular weights of PEG were selected, combined with two types of functional group modifications. The research showed that low-molecular-weight PEG possesses excellent osmotic effects and low viscosity characteristics, capable of carrying strontium ions deep into the tubules up to 140 μm that far exceeding the sealing depths reported in current research. Although the introduction of acrylic acid (AAC) functional groups enhanced crystal modulation and antibacterial properties, it involved a trade-off with reduced penetration depth and increased cytotoxicity, confirming that low-molecular-weight, electrically neutral PEG is the superior carrier choice. In conclusion, by clarifying fundamental mechanisms, this thesis elucidates the modes of ion penetration within dentinal tubules and successfully develops two nanocarrier systems: cyclodextrins and PEG. These systems overcome the limitations of traditional materials that rely on extreme pH levels, realizing a composite treatment mode that combines rapid penetration, deep mineralization, antibacterial efficacy, and the induction of vital pulp differentiation. These findings provide a scientific basis for addressing diseases derived from exposed dentinal tubules and serve as a significant reference for future therapeutic strategies. | en |
| dc.description.provenance | Submitted by admin ntu (admin@lib.ntu.edu.tw) on 2026-03-13T16:40:53Z No. of bitstreams: 0 | en |
| dc.description.provenance | Made available in DSpace on 2026-03-13T16:40:53Z (GMT). No. of bitstreams: 0 | en |
| dc.description.tableofcontents | 口試委員會審定書 i
誌謝 ii 中文摘要 iii 英文摘要 v 目 次 viii 圖 次 xiii 表 次 xvi 第一章 引言 1 1.1 研究背景 1 1.2 研究目的 1 1.3 研究範疇與具體目標 2 1.4 研究架構 3 第二章 文獻回顧 6 2.1 牙本質小管暴露成因與其引發的相關疾病 6 2.2 牙本質小管暴露的治療策略 7 2.2.1 物理封閉 7 2.2.2 化學封閉 8 2.2.3 神經去敏感化 9 2.2.4 雷射治療 11 2.3 本團隊於牙本質暴露相關疾病研究結果 13 2.3.1 傳統生物活性製劑 13 2.3.2 牙本質小管藥物滲透模型 13 2.3.3 攜帶離子的奈米藥物劑型 13 2.4 環狀糊精奈米材料用於治療暴露牙本質小管之優勢 14 2.4.1 環狀糊精於賦形劑之基礎與應用 14 2.4.2 環狀糊精作為抗菌材料之優勢 15 2.4.3 環狀糊精於攜帶離子鹽類之優勢 16 2.5 聚乙二醇奈米生醫材料用於暴露牙本質小管治療之優勢 17 2.5.1 聚乙二醇於生醫材料之基礎與應用 17 2.5.2 聚乙二醇作為抗菌材料之優勢 17 2.5.3 聚乙二醇對結晶生成之優勢與影響 17 第三章 材料與方法 19 3.1 無機離子透過牙本質小管的滲透模式與其機制研究 19 3.1.1 牙本質小管模型的建立 19 3.1.2 離子溶液配置 19 3.1.3 離子滲透模式評估 20 3.1.4 牙本質小管型態觀察 20 3.1.5 統計分析 20 3.2 攜帶離子的環狀糊精奈米複合物應用於牙本質小管的封填與抗菌 21 3.2.1 離子-環狀糊精配位複合物的製備與分析 21 3.2.2 體外沉澱行為評估 21 3.2.3 滲透能力評估 21 3.2.4 小管內閉塞和晶相分析 22 3.2.5 生物相容性測定 22 3.2.6 細胞增殖和分化測定 23 3.2.7 抗菌和抗生物膜評估 23 3.2.8 統計分析 24 3.3 攜帶離子的聚乙二醇與其衍生物對牙本質小管的深層封填 24 3.3.1 聚乙二醇及其衍生物的合成與特性分析 24 3.3.2 牙本質滲透模型與滲透能力評估 25 3.3.3 沉澱模式評估 25 3.3.4 牙本質小管封閉評估與晶體物相分析 25 3.3.5 細胞相容性與生物礦化誘導評估 26 3.3.6 抗菌活性測試 26 3.3.7 統計分析方法 26 第四章 結果 27 4.1 無機離子透過牙本質小管的滲透模式與其機制研究 27 4.1.1 正電荷於牙本質小管的滲透行為 27 4.1.2 負電荷於牙本質小管的滲透行為 31 4.1.3 整體性的離子滲透分析 33 4.1.4 牙本質小管型態 36 4.2 攜帶離子的環狀糊精奈米複合物應用於牙本質小管的封填與抗菌 52 4.2.1 環狀糊精奈米複合物的物理化學性質 52 4.2.2 離子-環狀糊精複合物的沉澱行為 53 4.2.3 牙本質滲透模式 55 4.2.4 離子-環狀糊精複合物於牙本質小管內結晶封閉評估 56 4.2.5 離子-環狀糊精複合物的結晶晶相分析 57 4.2.6 離子-環狀糊精複合物的細胞相容性 58 4.2.7 離子-環狀糊精複合物的細胞分化與增生 59 4.2.8 離子-環狀糊精複合物的抗菌能力評估 60 4.3 聚乙二醇奈米生醫材料用於暴露牙本質小管治療之優勢 63 4.3.1 聚乙二醇及其衍生物的化學性質分析 63 4.3.2 攜帶離子之聚乙二醇及其衍生物的性質分析 66 4.3.3 聚乙二醇及其衍生物的沉澱行為 70 4.3.4 牙本質滲透模式 72 4.3.5 聚乙二醇及其衍生物於牙本質小管內結晶封閉評估 74 4.3.6 聚乙二醇及其衍生物細胞相容性 77 4.3.7 聚乙二醇及其衍生物細胞分化與增生 78 4.3.8 聚乙二醇及其衍生物抗菌能力評估 78 第五章 討論 83 5.1 無機離子透過牙本質小管的滲透模式與其機制研究 83 5.1.1 離體牙本質小管滲透模型的標準化考量 83 5.1.2 牙本質微環境與靜電排斥效應 84 5.1.3 環境酸鹼值對醣胺聚糖和離子運輸的雙重調控機制 84 5.1.4 分子大小的空間限制效應 85 5.1.5 研究的局限性 85 5.1.6 第一部分研究貢獻 86 5.2 環狀糊精奈米複合物應用於牙本質小管的封填與抗菌 87 5.2.1 環狀糊精離子負載與複合機理 87 5.2.2 牙本質滲透與礦化調控 87 5.2.3 生物相容性與再生潛力 88 5.2.4 抗菌活性與機制 88 5.2.5 研究的局限性 89 5.2.6 第二部分研究貢獻 89 5.3 聚乙二醇奈米生醫材料用於暴露牙本質小管治療 90 5.3.1 滲透能力與結構設計的權衡 90 5.3.2 結晶能力的調控機制 90 5.3.3 生物相容性與活髓再生潛力 91 5.3.4 抗菌能力 91 5.3.5 研究的局限性 93 5.3.6 第三部分研究貢獻 93 5.4 整體載體評估 94 5.5 離子滲透與結晶機制 95 5.5.1 陽離子類型的決定性影響 95 5.5.2 磷酸根陰離子形態與pH的交互作用 95 5.6 生醫製劑在不同pH下的沈積機制 95 5.6.1 傳統生醫玻璃或生醫陶瓷製劑的挑戰 96 5.6.2 奈米載體製劑作為克服牙本質靜電屏障的策略與機制 96 第六章 總結 99 參考文獻 100 附錄 119 | - |
| dc.language.iso | zh_TW | - |
| dc.subject | 牙本質暴露 | - |
| dc.subject | 牙本質小管 | - |
| dc.subject | 離子滲透 | - |
| dc.subject | 生物活性製劑 | - |
| dc.subject | 藥物遞送 | - |
| dc.subject | Exposed dentin | - |
| dc.subject | Dentinal tubules | - |
| dc.subject | Ion penetration | - |
| dc.subject | Bioactive agents | - |
| dc.subject | Drug delivery | - |
| dc.title | 包覆離子之奈米生醫材料於牙本質小管滲透及結晶機制之探討 | zh_TW |
| dc.title | Permeation and crystallization mechanisms of ions encapsulated nano-biomaterials in dentinal tubules | en |
| dc.type | Thesis | - |
| dc.date.schoolyear | 114-1 | - |
| dc.description.degree | 博士 | - |
| dc.contributor.coadvisor | 鄭世榮 | zh_TW |
| dc.contributor.coadvisor | Shih-Jung Cheng | en |
| dc.contributor.oralexamcommittee | 劉緒宗;陳民樺 ;謝明發 | zh_TW |
| dc.contributor.oralexamcommittee | Shiuh-Tzung Liu;Min-Hua Chen ;Ming-Fa Hsieh | en |
| dc.subject.keyword | 牙本質暴露,牙本質小管離子滲透生物活性製劑藥物遞送 | zh_TW |
| dc.subject.keyword | Exposed dentin,Dentinal tubulesIon penetrationBioactive agentsDrug delivery | en |
| dc.relation.page | 119 | - |
| dc.identifier.doi | 10.6342/NTU202600199 | - |
| dc.rights.note | 未授權 | - |
| dc.date.accepted | 2026-01-22 | - |
| dc.contributor.author-college | 醫學院 | - |
| dc.contributor.author-dept | 口腔生物科學研究所 | - |
| dc.date.embargo-lift | N/A | - |
| 顯示於系所單位: | 口腔生物科學研究所 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-114-1.pdf 未授權公開取用 | 7.92 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
